RetinalGenix Technologies Inc.
RTGN
Rank in Stocks
#20989
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Share Price
$3.99
Last synced: 2026-11-06
Market Cap
$75.19M
Change (1 day)
0.00%
Change (1 year)
24.69%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade RetinalGenix Technologies Inc. (RTGN)
Category
Healthcare
EPS for RetinalGenix Technologies Inc. (RTGN)
EPS as of June 2026 TTM: $-0.11
According to RetinalGenix Technologies Inc.'s latest financial reports, its current EPS (TTM) is $-0.11. At the end of 2025 the company had an EPS of $-0.13, an increase over its 2024 EPS of $-0.24.
EPS history for RetinalGenix Technologies Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.11 | -15.38% |
| 2025 | $-0.13 | -45.83% |
| 2024 | $-0.24 | 100.00% |
| 2023 | $-0.12 | -52.00% |
| 2022 | $-0.25 | 66.67% |
| 2021 | $-0.15 | 186.81% |
| 2020 | $-0.05 | 128.38% |
| 2019 | $-0.02 | 22,800.00% |
| 2018 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -2,554.55% |
US
|
|
| $4.09 | -3,818.18% |
IE
|
|
| $9.45 | -8,690.91% |
US
|
|
| $2.37 | -2,254.55% |
US
|
|
| $1.77 | -1,709.09% |
US
|
Questions about RetinalGenix Technologies Inc.'s earnings per share (EPS)
What is RetinalGenix Technologies Inc.'s earnings per share (EPS)?
RetinalGenix Technologies Inc.'s earnings per share (EPS) over the last twelve months is $-0.11, as of Jun 2026.
What was RetinalGenix Technologies Inc.'s earnings per share (EPS) in 2025?
In 2025, RetinalGenix Technologies Inc.'s earnings per share (EPS) was $-0.13, compared with $-0.24 in 2024.
How has RetinalGenix Technologies Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, RetinalGenix Technologies Inc.'s earnings per share (EPS) was highest in 2020 ($-0.05) and lowest in 2022 ($-0.25).
How does RetinalGenix Technologies Inc.'s earnings per share (EPS) compare with similar companies?
RetinalGenix Technologies Inc.'s earnings per share (EPS) ($-0.11) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.